LYVMEO Trademark

Trademark Overview


On Tuesday, July 18, 2023, a trademark application was filed for LYVMEO with the United States Patent and Trademark Office. The USPTO has given the LYVMEO trademark a serial number of 79378145. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Thursday, September 26, 2024. This trademark is owned by Boehringer Ingelheim International GmbH. The LYVMEO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism; pharmaceutical preparations for the prevention and treatment of diseases and disorders and of the blood and blood forming organs; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; pharmaceutical preparations for the treatment and prevent...
lyvmeo

General Information


Serial Number79378145
Word MarkLYVMEO
Filing DateTuesday, July 18, 2023
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateThursday, September 26, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism; pharmaceutical preparations for the prevention and treatment of diseases and disorders and of the blood and blood forming organs; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections; pharmaceutical preparations for the prevention and treatment of oncological and auto-immune diseases and disorders; pharmaceutical preparations, namely, cell based immune therapeutics for treatment of cancer, for treatment of immunological diseases, and treatment of infectious diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 15, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events


Event DateEvent Description
Thursday, September 7, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, September 19, 2023APPLICATION FILING RECEIPT MAILED
Wednesday, September 13, 2023LIMITATION FROM ORIGINAL APPLICATION ENTERED
Friday, September 15, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 8, 2024ASSIGNED TO EXAMINER
Monday, March 11, 2024NON-FINAL ACTION WRITTEN
Tuesday, March 12, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, March 29, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, September 26, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 26, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 26, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 24, 2024REFUSAL PROCESSED BY IB
Friday, March 29, 2024REFUSAL PROCESSED BY MPU